Search Results 141-150 of 17055 for EBV

  1. A Study to Evaluate the Safety and Effectiveness of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Evaluating the Safety and Effectiveness of PF-06650833, PF-06700841, and PF-06826647 in Adults with Moderate-to-Severe Hidradenitis Suppurativa - Mayo Clinic

    History of any lymphoproliferative disorder (such as Epstein-Barr virus [EBV] – related lymphoproliferative disorder, history of lymphoma, leukemia, or signs ...

  2. Publications - Rebecca L. King, M.D. - Mayo Clinic

    Epstein Barr Virus-Negative Lymphoplasmacytic Proliferation ... EBV-Positive Plasmacytomas Involving a Nasopharyngeal Angiofibroma in an Adolescent.

  3. Treatment of Brain AVMs (TOBAS) Study - Clinical Trials

    The purpose of this study is to offer the best management possible for patients with brain arteriovenous malformations (AVMs) (ruptured or unruptured) in terms ...

  4. Non Hodgkin Clinical Trials - Mayo Clinic Research

    To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL) ...

  5. Study to Evaluate Chemoembolization Combined with Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma - Mayo Clinic

    Inclusion Criteria: Male and/or female. Age ≥ 18 years at the time of screening. For patients aged < 20 years and enrolled in Japan, a written informed ...

  6. A Study of Everolimus with or without Bevacizumab for Treating Patients with Advanced Kidney Cancer that Progressed after First-Line Therapy - Mayo Clinic

    Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as bevacizumab, can interfere ...

  7. https://www.mayoclinic.org/chinese_patient_consumer_video.xml

  8. A Study to Evaluate the Effectiveness and Safety of Camidanlumab Tesirine (ADCT-301) in Patients with Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    History of recent infection (within 4 weeks of C1D1) considered to be caused by one of the following pathogens: HSV1, HSV2, VZV, EBV, CMV, measles ...

  9. Publications - Matthew J. Binnicker, Ph.D. - Mayo Clinic

    ... Epstein-Barr virus, and BK virus in clinical specimens. J Clin Microbiol. 2014 May; 52 (5):1711-3 Epub 2014 Feb 19. View PubMed; Theel ES, Jespersen DJ ...

  10. Publications - Muhamad Alhaj Moustafa, M.D., M.S. - Mayo Clinic

    Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis. Clin Case Rep. 2021 May; 9 (5):e03971 Epub ...